Stockreport

How The Ocugen (OCGN) Story Is Shifting With Gene Therapy Milestones And Valuation Debate [Yahoo! Finance]

Ocugen, Inc.  (OCGN) 
PDF Ocugen's latest analyst update keeps the central fair value estimate at US$11.57, while published price targets from different firms span US$10, US$12 and US$22. That s [Read more]